Suppr超能文献

上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发的预后因素。

Prognostic factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.

作者信息

Chen Chen-Ya, Chang Chao-Hsiang, Yang Chi-Rei, Hsieh Kun-Lin, Tsing Wen-Hsin, Chen I-Hsuan Alan, Lin Jen-Tai, Huang Chao-Yuan, Hong Jian-Hua, Tseng Jen-Shu, Lin Wun-Rong, Tsai Yao-Chou, Wu Shu-Yu, Shen Cheng-Huang, Cheong Ian-Seng, Chen Chuan-Shu, Yang Cheng-Kuang, Jiang Yuan-Hong, Tsai Chung-You, Hsueh Thomas Y, Chen Yung-Tai, Wu Chia-Chang, Lo Shih-Hsiu, Chiang Bing-Juin, Lin Wei Yu, Lin Po-Hung, Tai Ta-Yao, Li Wei-Ming, Lee Hsiang-Ying

机构信息

Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

Department of Urology, China Medical University and Hospital, Taichung, Taiwan.

出版信息

World J Urol. 2024 Jan 10;42(1):22. doi: 10.1007/s00345-023-04700-9.

Abstract

PURPOSE

To evaluate predictive factors of increasing intravesical recurrence (IVR) rate in patients with upper tract urothelial carcinoma (UTUC) after receiving radical nephroureterectomy (RNUx) with bladder cuff excision (BCE).

MATERIALS AND METHODS

A total of 2114 patients were included from the updated data of the Taiwan UTUC Collaboration Group. It was divided into two groups: IVR-free and IVR after RNUx, with 1527 and 587 patients, respectively. To determine the factors affecting IVR, TNM stage, the usage of pre-operative ureteroscopy, and pathological outcomes were evaluated. The Kaplan-Meier estimator was used to estimate the rates of prognostic outcomes in overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), and bladder recurrence-free survival (BRFS), and the survival curves were compared using the stratified log-rank test.

RESULTS

Based on our research, ureter tumor, female, smoking history, age (< 70 years old), multifocal tumor, history of bladder cancer were determined to increase the risk of IVR after univariate analysis. The multivariable analysis revealed that female (BRFS for male: HR 0.566, 95% CI 0.469-0.681, p < 0.001), ureter tumor (BRFS: HR 1.359, 95% CI 1.133-1.631, p = 0.001), multifocal (BRFS: HR 1.200, 95% CI 1.001-1.439, p = 0.049), history of bladder cancer (BRFS: HR 1.480, 95% CI 1.118-1.959, p = 0.006) were the prognostic factors for IVR. Patients who ever received ureterorenoscopy (URS) did not increase the risk of IVR.

CONCLUSION

Patients with ureter tumor and previous bladder UC history are important factors to increase the risk of IVR after RNUx. Pre-operative URS manipulation is not associated with higher risk of IVR and diagnostic URS is feasible especially for insufficient information of image study. More frequent surveillance regimen may be needed for these patients.

摘要

目的

评估接受根治性肾输尿管切除术(RNUx)并膀胱袖口切除术(BCE)的上尿路尿路上皮癌(UTUC)患者膀胱内复发(IVR)率增加的预测因素。

材料与方法

从台湾UTUC协作组的更新数据中纳入了总共2114例患者。将其分为两组:RNUx术后无IVR组和IVR组,分别有1527例和587例患者。为了确定影响IVR的因素,评估了TNM分期、术前输尿管镜检查的使用情况和病理结果。采用Kaplan-Meier估计器来估计总生存(OS)、癌症特异性生存(CSS)、无病生存(DFS)和无膀胱复发生存(BRFS)的预后结局发生率,并使用分层对数秩检验比较生存曲线。

结果

基于我们的研究,单因素分析确定输尿管肿瘤、女性、吸烟史、年龄(<70岁)、多灶性肿瘤、膀胱癌病史会增加IVR风险。多变量分析显示,女性(男性BRFS:HR 0.566,95%CI 0.469-0.681,p<0.001)、输尿管肿瘤(BRFS:HR 1.359,95%CI 1.133-1.631,p=0.001)、多灶性(BRFS:HR 1.200,95%CI 1.001-1.439,p=0.049)、膀胱癌病史(BRFS:HR 1.480,95%CI 1.118-1.959,p=0.006)是IVR的预后因素。曾接受输尿管肾镜检查(URS)的患者并未增加IVR风险。

结论

输尿管肿瘤和既往膀胱UC病史的患者是RNUx术后IVR风险增加的重要因素。术前URS操作与IVR的较高风险无关,诊断性URS是可行的,特别是对于影像学检查信息不足的情况。这些患者可能需要更频繁的监测方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验